O-1602

Name O-1602
Supplier R&D Systems
Catalog 2797
Prices $199.00
Sizes 10 mg
Cas Number 317321-41-8
Chemical Name 5-Methyl-4-[(1R,6R)-3-methyl-6-(1-cyclohexen-1-yl]-1,3-benzenediol
Formula C17H22O2
Molecular Weight 258.36
Purity >98%
Supplier Page Shop

Product References

Addition of lysophospholipids with large head groups to cells inhibits Shiga - Addition of lysophospholipids with large head groups to cells inhibits Shiga

Ailte I, Lingelem AB, Kavaliauskiene S, Bergan J, Kvalvaag AS, Myrann AG, Skotland T, Sandvig K. Sci Rep. 2016 Jul 26;6:30336.

Delta(9)-Tetrahydrocannabinol treatment during human monocyte differentiation - Delta(9)-Tetrahydrocannabinol treatment during human monocyte differentiation

Williams JC, Appelberg S, Goldberger BA, Klein TW, Sleasman JW, Goodenow MM. J Neuroimmune Pharmacol. 2014 Jun;9(3):369-79.

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. - A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.

Romero-Zerbo SY, Rafacho A, Diaz-Arteaga A, Suarez J, Quesada I, Imbernon M, Ross RA, Dieguez C, Rodriguez de Fonseca F, Nogueiras R, Nadal A, Bermudez-Silva FJ. J Endocrinol. 2011 Nov;211(2):177-85.

The atypical cannabinoid O-1602 protects against experimental colitis and - The atypical cannabinoid O-1602 protects against experimental colitis and

Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M. Inflamm Bowel Dis. 2011 Aug;17(8):1651-64.

Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors - Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors

Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC. Br J Pharmacol. 2010 Feb;159(4):787-96.